Addiction Medicine,
Edition 2 Science and PracticeEditors: By Bankole Johnson
Publication Date:
12 Dec 2019
Conformance
-
PDF/UA-1
-
The publication was certified on 20250728
-
For queries regarding accessibility information, contact [email protected]
Ways Of Reading
-
This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation.
Navigation
-
The contents of the PDF have been tagged to permit access by assistive technologies as per PDF-UA-1 standard.
-
Page breaks included from the original print source
Additional Accessibility Information
-
The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
Note
-
This product relies on 3rd party tooling which may impact the accessibility features visible in inspection copies. All accessibility features mentioned would be present in the purchased version of the title.
Description
Integrating scientific knowledge with today’s most effective treatment options, Addiction Medicine: Science and Practice, 2nd Edition, provides a wealth of information on addictions to substances and behavioral addictions. It discusses the concrete research on how the brain and body are affected by addictions, improving your understanding of how patients develop addictions and how best to personalize treatment and improve outcomes. This essential text is ideal for anyone who deals with patients with addictions in clinical practice, including psychiatrists, health psychologists, pharmacologists, social workers, drug counselors, trainees, and general physicians/family practitioners.
Key Features
- Clearly explains the role of brain function in drug taking and other habit-forming behaviors, and shows how to apply this biobehavioral framework to the delivery of evidence-based treatment.
- Provides clinically relevant details on not only traditional sources of addiction such as cocaine, opiates, and alcohol, but also more recently recognized substances of abuse (e.g., steroids, inhalants) as well as behavioral addictions (e.g., binge eating, compulsive gambling, hoarding).
- Discusses current behavioral and medical therapies in depth, while also addressing social contexts that may affect personalized treatment.
- Contains new information on compliance-enhancing interventions, cognitive behavioral treatments, behavioral management, and other psychosocial interventions.
- Includes neurobiological, molecular, and behavioral theories of addiction, and includes a section on epigenetics.
- Contains up-to-date information throughout, including a new definition of status epilepticus, a current overview of Lennox Gastaut syndrome, and updates on new FDA-approved drugs for pediatric neurological disorders.
- Features expanded sections on evidence-based treatment options including pharmacotherapy, pharmacogenetics, and potential vaccines.
- Addresses addiction in regards to specific populations, including adolescents, geriatric, pregnant women, and health care professionals.
- Includes contributions from expert international authors, making this a truly global reference to addiction medicine.
- Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
About the author
By Bankole Johnson
Part I: History, Perspective, Epidemiology, Dx and Classification
1. Emerging Health Perspectives
2. The Epidemiology of Alcohol and Drug Disorders
3. United States Federal Drug Policy
4. Historical Perspectives of Addiction
5. Diagnosis and Classification of Substance Use Disorders
Part II: Behavioral Theories for Substance Use Disorder
6. Drug Reinforcement in Animals
7. Role of the Human Laboratory Studies in the Development of Medications for Alcohol and Substance Abuse Disorders
8. Conditioning of Addiction
9. Overlapping Striatal Circuits and Molecular Mechanisms in Rodent Models of Addiction and Depression
10. The Role of Endocannabinoids in Amphetamine-Driven Actions in Dopamine Neurons: Implications for Understanding and Treating Dysfunction in the Mesolimbic Circuit
11. Pain and Negative Affect
12. Genetic Vulnerability to Substance Use Disorders
13. Assessment and Treatment of Addiction in Best Practices and New Frontiers in a Direct to Consumer Age
14. Metabolomics in Drug Response and Addiction
Part III: Visualizations and Workings of the Addicted Brain
15. Visualization and Workings of the Addicted Brain
16. Neurobiological Basis of Drug Reward and Reinforcement
17. Neurobehavioral Toxicology of Substances of Abuse
18. Animal Models of Substance Use Disorders: Motivational Perspective
19. Novel Methodologies: Proteomic Approaches in Substance Abuse Research
20. Neuroinflammatory Processes in Drug Addiction
Part IV: Clinical Aspects of Alcohol and Drug Addiction
21. Alcohol: Clinical Aspects
22. Cocaine
23. Nicotine
24. Cannabis: An Overview of the Empirical Literature
25. Opiates and Prescription Drugs
26. Clinical Aspects of Methamphetamine
27. Sedative-Hypnotics and Anxiolytics
28. Clinical Aspects of Inhalant Addiction
29. Anabolic-Androgenic Steroids
30. Caffeine
31. Serotonergic Hallucinogens
32. Ketamine and Phencyclidine
Part V: Behavioral Addictions and Treatment
33. The Biology and Treatment of Pathological Gambling
34. Implications of "Food Addiction" for Understanding and Treating Binge Eating Disorder
35. Compulsive Buying
36. Sexual Behavior as an Addictive or Compulsive Phenomenon
37. New Era of Internet Addiction Research in China
38. Hoarding as a Behavioral Addiction
Part VI: Treatment and Application: Behavioral Treatments
39. Motivational Interviewing: Emerging Theory, Research, and Practice
40. Cognitive Behavioral Therapy for Addiction
41. Community Reinforcement Approach and Contingency Management Therapies
42. Relapse Prevention and Recycling in Addiction
43. Brief and e-Health Interventions for the Treatment of Alcohol or Other Drug Addiction
44. Self-Help Approaches for Addiction
Section VII: Treatment and Application: Group Treatments and Specific Settings
45. Community Clinics
46. Unhealthy Alcohol and Other Drug Use in Primary Care
47. Criminal Justice System and Addiction Treatment
48. Adolescent Neurocognitive Development and School-Based Drug Abuse Prevention and Treatment
49. The Therapeutic Community for Drug-Abuse Treatment: A Journey Yet Unfolding in the Recovery Movement
50. Substance Use-Focused Mutual-Help Groups: Processes and Outcomes
Section VIII: Treatment and Application Pharmacotherapy
51. Pharmacotherapy for Alcoholism and Some Related Psychiatric and Addictive Disorders: Scientific Basis and Clinical Findings
52. Alcohol Withdrawal: Treatment and Application
53. Pharmacotherapy of Cocaine Addiction
54. Opioid Overdose
55. Methamphetamine
56. Potential Pharmacotherapies for Cannabis Dependence
57. Hallucinogens
Section IX: Molecular Genetics, Alternative Therapies, and Other Topics in the Treatment of Addiction
58. Molecular Genetics and the Treatment of Addiction
59. Physical Considerations for Treatment Complications of Alcohol and Drug Use and Misuse
60. Quadruple Diagnosis: Substance Use Disorder, Comorbid Psychopathology, Human Immunodeficiency Virus Infection, and Hepatitis C Virus Infection
61. Substance Use Stigma as a Barrrier to Treatment and Recovery
62. Religiousness, Spirituality, and Addiction: An Evidence-Based Review
Section X: Computer Modeling
63. In Silico Models of Alcohol Kinetics: A Deterministic Approach
64. In Silico Models of Alcohol Dependence Treatment: Stochastic Approach
65. Dynamic and Systems-Based Models for Evaluating Hypotheses Related to Predicting Treatment Response
Part XI: Dependence in Specific Populations
66. Enhancing Positive Outcomes for Children of Substance-Abusing Parents
67. Alcohol and Substance Abuse in African Americans
68. Gays, Lesbians, and Bisexuals
69. Substance Use Disorders in Health Care Professionals
70. Identification and Treatment of Alcohol or Drug Dependence in the Elderly
71. Alcohol and Drugs of Abuse in Pregnant Women: Effects on Fetus and Newborn, Mode of Action, and Maternal Treatment
Part XII: Legal, Disability and Rehabilitative Issues
72. Forensic Issues
73. Disability and Addiction
74. The Homeless
75. To Open Up New Vistas in Basic and Preclinical Addiction Research
1. Emerging Health Perspectives
2. The Epidemiology of Alcohol and Drug Disorders
3. United States Federal Drug Policy
4. Historical Perspectives of Addiction
5. Diagnosis and Classification of Substance Use Disorders
Part II: Behavioral Theories for Substance Use Disorder
6. Drug Reinforcement in Animals
7. Role of the Human Laboratory Studies in the Development of Medications for Alcohol and Substance Abuse Disorders
8. Conditioning of Addiction
9. Overlapping Striatal Circuits and Molecular Mechanisms in Rodent Models of Addiction and Depression
10. The Role of Endocannabinoids in Amphetamine-Driven Actions in Dopamine Neurons: Implications for Understanding and Treating Dysfunction in the Mesolimbic Circuit
11. Pain and Negative Affect
12. Genetic Vulnerability to Substance Use Disorders
13. Assessment and Treatment of Addiction in Best Practices and New Frontiers in a Direct to Consumer Age
14. Metabolomics in Drug Response and Addiction
Part III: Visualizations and Workings of the Addicted Brain
15. Visualization and Workings of the Addicted Brain
16. Neurobiological Basis of Drug Reward and Reinforcement
17. Neurobehavioral Toxicology of Substances of Abuse
18. Animal Models of Substance Use Disorders: Motivational Perspective
19. Novel Methodologies: Proteomic Approaches in Substance Abuse Research
20. Neuroinflammatory Processes in Drug Addiction
Part IV: Clinical Aspects of Alcohol and Drug Addiction
21. Alcohol: Clinical Aspects
22. Cocaine
23. Nicotine
24. Cannabis: An Overview of the Empirical Literature
25. Opiates and Prescription Drugs
26. Clinical Aspects of Methamphetamine
27. Sedative-Hypnotics and Anxiolytics
28. Clinical Aspects of Inhalant Addiction
29. Anabolic-Androgenic Steroids
30. Caffeine
31. Serotonergic Hallucinogens
32. Ketamine and Phencyclidine
Part V: Behavioral Addictions and Treatment
33. The Biology and Treatment of Pathological Gambling
34. Implications of "Food Addiction" for Understanding and Treating Binge Eating Disorder
35. Compulsive Buying
36. Sexual Behavior as an Addictive or Compulsive Phenomenon
37. New Era of Internet Addiction Research in China
38. Hoarding as a Behavioral Addiction
Part VI: Treatment and Application: Behavioral Treatments
39. Motivational Interviewing: Emerging Theory, Research, and Practice
40. Cognitive Behavioral Therapy for Addiction
41. Community Reinforcement Approach and Contingency Management Therapies
42. Relapse Prevention and Recycling in Addiction
43. Brief and e-Health Interventions for the Treatment of Alcohol or Other Drug Addiction
44. Self-Help Approaches for Addiction
Section VII: Treatment and Application: Group Treatments and Specific Settings
45. Community Clinics
46. Unhealthy Alcohol and Other Drug Use in Primary Care
47. Criminal Justice System and Addiction Treatment
48. Adolescent Neurocognitive Development and School-Based Drug Abuse Prevention and Treatment
49. The Therapeutic Community for Drug-Abuse Treatment: A Journey Yet Unfolding in the Recovery Movement
50. Substance Use-Focused Mutual-Help Groups: Processes and Outcomes
Section VIII: Treatment and Application Pharmacotherapy
51. Pharmacotherapy for Alcoholism and Some Related Psychiatric and Addictive Disorders: Scientific Basis and Clinical Findings
52. Alcohol Withdrawal: Treatment and Application
53. Pharmacotherapy of Cocaine Addiction
54. Opioid Overdose
55. Methamphetamine
56. Potential Pharmacotherapies for Cannabis Dependence
57. Hallucinogens
Section IX: Molecular Genetics, Alternative Therapies, and Other Topics in the Treatment of Addiction
58. Molecular Genetics and the Treatment of Addiction
59. Physical Considerations for Treatment Complications of Alcohol and Drug Use and Misuse
60. Quadruple Diagnosis: Substance Use Disorder, Comorbid Psychopathology, Human Immunodeficiency Virus Infection, and Hepatitis C Virus Infection
61. Substance Use Stigma as a Barrrier to Treatment and Recovery
62. Religiousness, Spirituality, and Addiction: An Evidence-Based Review
Section X: Computer Modeling
63. In Silico Models of Alcohol Kinetics: A Deterministic Approach
64. In Silico Models of Alcohol Dependence Treatment: Stochastic Approach
65. Dynamic and Systems-Based Models for Evaluating Hypotheses Related to Predicting Treatment Response
Part XI: Dependence in Specific Populations
66. Enhancing Positive Outcomes for Children of Substance-Abusing Parents
67. Alcohol and Substance Abuse in African Americans
68. Gays, Lesbians, and Bisexuals
69. Substance Use Disorders in Health Care Professionals
70. Identification and Treatment of Alcohol or Drug Dependence in the Elderly
71. Alcohol and Drugs of Abuse in Pregnant Women: Effects on Fetus and Newborn, Mode of Action, and Maternal Treatment
Part XII: Legal, Disability and Rehabilitative Issues
72. Forensic Issues
73. Disability and Addiction
74. The Homeless
75. To Open Up New Vistas in Basic and Preclinical Addiction Research
Title Reviews
Doody's Core Titles® 2022
ISBN:
9780323754408
Page Count:
1136
Illustrations
:
150
Retail Price (USD)
:
General Psychiatrist and Psychiatrist in Addiction Medicine.
